L218CAR19

· Henan Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L218CAR19, covering 2024-06-27 to 2024-06-27. Get the full timeline:

Most recent: Clinical Trial Update: L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma [Phase 1]